CDMOs are Outsourcing Buffers to Increase Agility and Efficiency

CDMOs are Outsourcing Buffers to Increase Agility and Efficiency

Upstream processing advancements are driving higher yields and increasing batch volumes, placing growing strain on downstream operations—particularly in buffer preparation and management. Biologics manufacturers are thus turning to mitigation strategies, such as strategic outsourcing, to improve efficiency and scalability. Shifting the production of high-volume buffers to external suppliers can reduce storage burdens, enhance operational flexibility, and free internal capacity for process-specific activities.

Learn more about the benefits of buffer outsourcing in this application note from Thermo Fisher Scientific!

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.


  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.

  • By submitting this form, you consent to Pharmaceutical Outsourcing storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.